한글목차

간 질환 진단 약물의 동향과 예측

세계 간 질환 진단 시장은 2024년부터 2030년까지 복합 연간 성장률(CAGR) 6.2%를 나타낼 전망이며 2030년에는 505억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 간 질환의 유병률 증가, 알코올 소비 증가, 환자의 정확하고 조기 진단을위한 연구 개발에 대한 지출 증가입니다. 세계 간 질환 진단 시장의 미래는 병원 시장과 연구시설 시장의 비즈니스 기회에 의해 유망시되고 있습니다.

간 질환 진단 시장 인사이트

Lucintel은 간 질환 진단 시장의 주요 기업이 첨단 영상 진단 기술을 개발하기 위한 많은 이니셔티브를 갖고 있기 때문에 예측 기간 동안 영상 진단이 가장 큰 부문이 될 것으로 예측했습니다.

이 시장에서 입원 환자 증가, 진보된 진단 제품의 가용성, 충분한 훈련을 받은 간호 직원의 존재로 인해 병원은 계속해서 최대 부문이 됩니다.

아시아태평양은 건강 관리 지출 증가, 노인 인구 증가, 정기 검진에 대한 의식 증가로 예측 기간 동안 가장 높은 성장이 예상됩니다.

이 보고서는 다음 11가지 주요 질문에 답변합니다.

• Q.1. 시장 부문 중 가장 유망하고 고성장하는 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장하는지, 그리고 그 이유는?
• Q.3. 앞으로 성장이 가속될 것으로 보이는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은?
• Q.6. 이 시장에서의 새로운 동향과 그 이유는?
• Q.7. 시장에서 고객 수요 변화에는 어떤 것이 있는가?
• Q.8. 이 시장에서의 새로운 개발과 그 개발을 리드하고 있는 기업은?
• Q.9.이 시장의 주요 기업은? 주요 기업은 사업 성장을 위해 어떤 전략적 노력을 추진하고 있는가?
• Q.10. 이 시장에서 경쟁 제품은 어떠한 것이며, 재료 및 제품 대체로 인한 시장 점유율 저하의 위협은 어느 정도입니까?
• Q.11. 지난 5년 동안 어떤 M&D가 수행되었고 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 간 질환 진단 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 간 질환 진단 시장 동향(2018-2023년)과 예측(2024-2030년)
• 진단 기술별 세계의 간 질환 진단 시장
  • 이미지화
  • 임상 검사
  • 내시경 검사
  • 생검
  • 기타
• 최종 용도별 세계의 간 질환 진단 시장
  • 병원
  • 연구실
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 간 질환 진단 시장
• 북미 간 질환 진단 시장
• 유럽의 간 질환 진단 시장
• 아시아태평양의 간 질환 진단 시장
• 기타 지역 간 질환 진단 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상의 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 진단 기술별 세계의 간 질환 진단 시장의 성장 기회
  • 최종 용도별 세계의 간 질환 진단 시장의 성장 기회
  • 지역별 세계의 간 질환 진단 시장의 성장 기회
• 세계의 간 질환 진단 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 간 질환 진단 시장의 능력 확대
  • 세계 간 질환 진단 시장에서의 합병, 인수, 합작 사업
  • 인증 및 라이센스

제7장 유력 기업의 기업 프로파일

• Abbott
• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• Randox Laboratories
• Boston Scientific Corporation
• Laboratory Corporation of America Holdings
• Fujifilm Corporation
• Horiba Medical
• Siemens Healthcare

영문목차

Liver Disease Diagnostics Trends and Forecast

The future of the global liver disease diagnostics market looks promising with opportunities in the hospital and laboratoy markets. The global liver disease diagnostics market is expected to reach an estimated $50.5 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are increasing prevalence of liver diseases, rising alcohol consumption, and growing expenditure on research and development for accurate and early diagnosis of patients.

A more than 150-page report is developed to help in your business decisions.

Liver Disease Diagnostics by Segment

The study includes a forecast for the global liver disease diagnostics by diagnosis technique, end use, and region.

Liver Disease Diagnostics Market by Diagnosis Technique [Shipment Analysis by Value from 2018 to 2030]:

• Imaging
• Laboratory tests
• Endoscopy
• Biopsy
• Others

Liver Disease Diagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Laboratories
• Others

Liver Disease Diagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Liver Disease Diagnostics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies liver disease diagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the liver disease diagnostics companies profiled in this report include-

• Abbott
• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• Randox Laboratories
• Boston Scientific Corporation
• Laboratory Corporation Of America Holdings
• Fujifilm Corporation
• Horiba Medical
• Siemens Healthcare

Liver Disease Diagnostics Market Insights

Lucintel forecasts that imaging will remain the largest segment over the forecast period due to the growing number of initiatives taken by key players in the market for liver disease diagnostics so as to develop advanced imaging techniques.

Within this market, hospitals will remain the largest segment due to growing admission of patient, availability of advanced diagnostic products, and presence of well-trained nursing staff.

APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, growing geriatric population, and rising awarness towards regular checkups in the region.

Features of the Global Liver Disease Diagnostics Market

Market Size Estimates: Liver disease diagnostics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Liver disease diagnostics market size by diagnosis technique, end use, and region. in terms of value ($B).

Regional Analysis: Liver disease diagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnosis techniques, end uses, and region.s for the liver disease diagnostics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the liver disease diagnostics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the liver disease diagnostics market size?

Answer: The global liver disease diagnostics market is expected to reach an estimated $50.5 billion by 2030.

Q.2. What is the growth forecast for liver disease diagnostics market?

Answer: The global liver disease diagnostics market is expected to grow with a CAGR of 6.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the liver disease diagnostics market?

Answer: The major drivers for this market are increasing prevalence of liver diseases, rising alcohol consumption, and growing expenditure on research and development for accurate and early diagnosis of patients.

Q.4. What are the major segments for liver disease diagnostics market?

Answer: The future of the liver disease diagnostics market looks promising with opportunities in the hospitals and laboratories markets.

Q.5. Who are the key liver disease diagnostics market companies?

Answer: Some of the key liver disease diagnostics companies are as follows:

• Abbott
• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• Randox Laboratories
• Boston Scientific Corporation
• Laboratory Corporation of America Holdings
• Fujifilm Corporation
• Horiba Medical
• Siemens Healthcare

Q.6. Which liver disease diagnostics market segment will be the largest in future?

Answer: Lucintel forecasts that imaging will remain the largest segment over the forecast period due to the growing number of initiatives taken by key players in the market for liver disease diagnostics so as to develop advanced imaging techniques.

Q.7. In liver disease diagnostics market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, growing geriatric population, and rising awarness towards regular checkups in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the liver disease diagnostics market by diagnosis technique (imaging, laboratory tests, endoscopy, biopsy, and others), end use (hospitals, laboratories, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Liver Disease Diagnostics Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Liver Disease Diagnostics Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Liver Disease Diagnostics Market by Diagnosis Technique
  • 3.3.1: Imaging
  • 3.3.2: Laboratory tests
  • 3.3.3: Endoscopy
  • 3.3.4: Biopsy
  • 3.3.5: Others
• 3.4: Global Liver Disease Diagnostics Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Laboratories
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Liver Disease Diagnostics Market by Region
• 4.2: North American Liver Disease Diagnostics Market
  • 4.2.2: North American Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others
• 4.3: European Liver Disease Diagnostics Market
  • 4.3.1: European Liver Disease Diagnostics Market by Diagnosis Technique: Imaging, Laboratory Tests, Endoscopy, Biopsy, and Others
  • 4.3.2: European Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others
• 4.4: APAC Liver Disease Diagnostics Market
  • 4.4.1: APAC Liver Disease Diagnostics Market by Diagnosis Technique: Imaging, Laboratory Tests, Endoscopy, Biopsy, and Others
  • 4.4.2: APAC Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others
• 4.5: ROW Liver Disease Diagnostics Market
  • 4.5.1: ROW Liver Disease Diagnostics Market by Diagnosis Technique: Imaging, Laboratory Tests, Endoscopy, Biopsy, and Others
  • 4.5.2: ROW Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Liver Disease Diagnostics Market by Diagnosis Technique
  • 6.1.2: Growth Opportunities for the Global Liver Disease Diagnostics Market by End Use
  • 6.1.3: Growth Opportunities for the Global Liver Disease Diagnostics Market by Region
• 6.2: Emerging Trends in the Global Liver Disease Diagnostics Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Liver Disease Diagnostics Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Liver Disease Diagnostics Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott
• 7.2: F. Hoffmann-La Roche
• 7.3: Thermo Fisher Scientific
• 7.4: Randox Laboratories
• 7.5: Boston Scientific Corporation
• 7.6: Laboratory Corporation of America Holdings
• 7.7: Fujifilm Corporation
• 7.8: Horiba Medical
• 7.9: Siemens Healthcare